Document Type
Article
Publication Date
3-10-2021
Abstract
Curative-intent radiotherapy plays an integral role in the treatment of lung cancer and therefore improving its therapeutic index is vital. MR guided radiotherapy (MRgRT) systems are the latest technological advance which may help with achieving this aim. The majority of MRgRT treatments delivered to date have been stereotactic body radiation therapy (SBRT) based and include the treatment of (ultra-) central tumors. However, there is a move to also implement MRgRT as curative-intent treatment for patients with inoperable locally advanced NSCLC. This paper presents the initial clinical experience of using the two commercially available systems to date: the ViewRay MRIdian and Elekta Unity. The challenges and potential solutions associated with MRgRT in lung cancer will also be highlighted.
Recommended Citation
Crockett, Cathryn B.; Samson, Pamela; Chuter, Robert; Dubec, Michael; Faivre-Finn, Corinne; Green, Olga L.; Hackett, Sara L.; McDonald, Fiona; Robinson, Clifford; Shiarli, Anna-Maria; Straza, Michael W; Verhoeff, Joost J.C.; Werner-Wasik, Maria; Vlacich, Gregory; and Cobben, David, "Initial Clinical Experience of MR-Guided Radiotherapy for Non-Small Cell Lung Cancer." (2021). Department of Radiation Oncology Faculty Papers. Paper 148.
https://jdc.jefferson.edu/radoncfp/148
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.
PubMed ID
33777759
Language
English
Comments
This article is the author’s final published version in Frontiers in Oncology, Volume 11, March 2021, Article number 617681.
The published version is available at https://doi.org/10.3389/fonc.2021.617681. Copyright © Crockett et al.